Versuchen GOLD - Frei
Driving Research Continuity in Indian R&D through Remote Lab Operations
Bio Spectrum
|September 2025
India's research landscape is undergoing rapid transformation as institutions look toward hybrid and remote working models to enhance flexibility and collaboration. By turning to cloudbased lab systems and AI-powered analytics, R&D organisations can build agile, future-ready environments to help power India's academic and industrial sectors.
-
Dr Mary Donlan, Executive Director, Product Marketing, Revvity Signals
The COVID-19 pandemic marked a turning point for research and development practices throughout the world. With restricted access to physical laboratories due to nationwide lockdowns, traditional on-site research models were disrupted overnight. In response, R&D organisations were compelled to adopt hybrid and remote research models, combining in-person lab work with digital off-site data analysis.
Ignited by the short-term necessity of COVID-19, digital R&D solutions have now evolved to redefine remote research frameworks and transform how research continuity is maintained. Moving from manual processes largely confined within the four walls of the lab to data-driven research that is independent of location, institutions have learned that the data itself represents the greatest store of value. As a result, reliable, flexible, secure access to lab-generated data is at a premium, and remote and cloud solutions have surged to fill a market gap.
For example, in a survey conducted soon after the start of the pandemic, Deloitte showed that drug companies rated cloud computing as one of the highest priorities of the following 5 years.
In the work-from-anywhere hybrid environment, it is no longer practical for data to be encased within physical lab notebooks or local data systems.
Researchers working from different locations require safe, real-time access, analysis and sharing of protocols and experimental results to maintain momentum in their projects and promote collaboration across departments and institutions.
In this new environment, cloud-based Electronic Lab Notebooks (ELNs) with AI-powered data analytic platforms play a key role. These solutions enable remote data accessibility, enhanced data integrity, and compliance with regulatory standards – crucial factors in both academic research and industrial R&D.
Diese Geschichte stammt aus der September 2025-Ausgabe von Bio Spectrum.
Abonnieren Sie Magzter GOLD, um auf Tausende kuratierter Premium-Geschichten und über 9.000 Zeitschriften und Zeitungen zuzugreifen.
Sie sind bereits Abonnent? Anmelden
WEITERE GESCHICHTEN VON Bio Spectrum
Bio Spectrum
Building Breakthrough Medical Devices
Dr Ria Khurana founded RNT Health Insights, a Chandigarh-based healthtech startup specialising in Al-assisted diagnostic solutions for the accurate detection of pathologies during endoscopic procedures, in 2022 along with Dr Tanmaya Gulati.
2 mins
January 2026
Bio Spectrum
Bridging classical epidemiology with modern science
A physician scientist with a MBBS from Lady Hardinge Medical College, (University of Delhi), a post-graduation in Paediatrics and a PhD from All India Institute of Medical Sciences (AIIMS), New Delhi, Prof.Shinjini Bhatnagar served as Professor of Eminence at Translational Health Science and Technology Institute (THSTI) until February 2023 and was subsequently appointed Distinguished Professor at THSTI until May 2025.
2 mins
January 2026
Bio Spectrum
"AI, Automation & Analytics: A new era of modern microbiology testing!"
Pharmaceutical manufacturing is undergoing a paradigm shift.
4 mins
January 2026
Bio Spectrum
The CRISPR Moment
CRISPR (clustered regularly interspaced short palindromic repeats) technology is ushering in a new era of gene and cell therapy, offering more precision and potential for treating genetic disorders, cancer, and infectious diseases.
2 mins
January 2026
Bio Spectrum
Leveraging Microfluidic Technology for mRNA-LNP Manufacturing
Over the past five years, messenger RNA (mRNA) therapeutics have evolved from experimental concepts into lifesaving medicines.
2 mins
January 2026
Bio Spectrum
Demonstrating India's Vaccine Capabilities
Havisure is India's first and only indigenously developed Hepatitis A vaccine, to address one of the country's most persistent public health challengeswidespread Hepatitis A infections caused by inadequate sanitation and contaminated food and water.
2 mins
January 2026
Bio Spectrum
Inspiring Future Generations
A PhD in molecular biology from the University of Cambridge, UK, Prof. Gaiti Hasan is a Distinguished Fellow at the National Centre for Biological Sciences (NCBS), Bengaluru.
2 mins
January 2026
Bio Spectrum
A Landmark for India's Antibiotic Innovation
After three decades of research and hard work, India has led the way with the creation of Nafithromycin, the country's first indigenous antibiotic.
2 mins
January 2026
Bio Spectrum
"Future vaccine innovation will be integration of R&D, regulatory support and manufacturing”
TechInvention Lifecare Limited, a vaccine focused biotechnology company headquartered in Mumbai, is recognised for its innovative contributions to global healthcare.
4 mins
January 2026
Bio Spectrum
Telangana: Building India's Most Credible Life Sciences Ecosystem
Telangana's recognition as BioSpectrum India's Best Performing State in Life Sciences 2025 is a timely validation of the direction the state has taken in recent years-one anchored in execution, responsiveness, and a clear understanding of where global life sciences value chains are headed.
4 mins
January 2026
Listen
Translate
Change font size
